Daihan Pharmaceutical Co.,Ltd. 023910.KQ Stock
Daihan Pharmaceutical Co.,Ltd. Price Chart
Daihan Pharmaceutical Co.,Ltd. 023910.KQ Financial and Trading Overview
Daihan Pharmaceutical Co.,Ltd. stock price | 27850 KRW |
Previous Close | 27900 KRW |
Open | 28000 KRW |
Bid | 28000 KRW x 0 |
Ask | 28300 KRW x 0 |
Day's Range | 28000 - 28300 KRW |
52 Week Range | 24250 - 32300 KRW |
Volume | 3.38K KRW |
Avg. Volume | 6.81K KRW |
Market Cap | 168.9B KRW |
Beta (5Y Monthly) | 0.374006 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
023910.KQ Valuation Measures
Enterprise Value | 90.93B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.93251914 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 0.502 |
Enterprise Value/EBITDA | 2.14 |
Trading Information
Daihan Pharmaceutical Co.,Ltd. Stock Price History
Beta (5Y Monthly) | 0.374006 |
52-Week Change | 6.48% |
S&P500 52-Week Change | 20.43% |
52 Week High | 32300 KRW |
52 Week Low | 24250 KRW |
50-Day Moving Average | 28428 KRW |
200-Day Moving Average | 28489.5 KRW |
023910.KQ Share Statistics
Avg. Volume (3 month) | 6.81K KRW |
Avg. Daily Volume (10-Days) | 9.89K KRW |
Shares Outstanding | 6M |
Float | 3.82M |
Short Ratio | N/A |
% Held by Insiders | 35.59% |
% Held by Institutions | 13.52% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor | 10:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | September 30, 2022 |
Next Fiscal Year End | December 31, 2022 |
Profitability
Profit Margin | 14.46% |
Operating Margin (ttm) | 18.13% |
Gross Margin | 32.97% |
EBITDA Margin | 23.45% |
Management Effectiveness
Return on Assets (ttm) | 7.45% |
Return on Equity (ttm) | 12.49% |
Income Statement
Revenue (ttm) | 181.12B KRW |
Revenue Per Share (ttm) | 30188.26 KRW |
Quarterly Revenue Growth (yoy) | 8.90% |
Gross Profit (ttm) | 55.68B KRW |
EBITDA | 42.49B KRW |
Net Income Avi to Common (ttm) | 26.2B KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | 16.69% |
Balance Sheet
Total Cash (mrq) | 107.87B KRW |
Total Cash Per Share (mrq) | 17978.86 KRW |
Total Debt (mrq) | 20.3B KRW |
Total Debt/Equity (mrq) | 9.15 KRW |
Current Ratio (mrq) | 3.898 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | 29.32B KRW |
Levered Free Cash Flow (ttm) | 17.79B KRW |
Profile of Daihan Pharmaceutical Co.,Ltd.
Country | South Korea |
State | N/A |
City | Seoul |
Address | 3, Seonyu-ro 45-gil |
ZIP | 07209 |
Phone | 82 2 2678 3911 |
Website | https://www.daihan.com |
Industry | |
Sector(s) | |
Full Time Employees | N/A |
Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. It offers various drugs, such as basic infusion solution, special infusion, injectable solutions, OTC drugs, dialysis solution, and quasi drugs. The company was formerly known as DAI HAN Pharmaceutical Chemistry, Co. and changed its name to Daihan Pharmaceutical Co.,Ltd. in 1978. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea.
Q&A For Daihan Pharmaceutical Co.,Ltd. Stock
What is a current 023910.KQ stock price?
Daihan Pharmaceutical Co.,Ltd. 023910.KQ stock price today per share is 27850 KRW.
How to purchase Daihan Pharmaceutical Co.,Ltd. stock?
You can buy 023910.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Daihan Pharmaceutical Co.,Ltd.?
The stock symbol or ticker of Daihan Pharmaceutical Co.,Ltd. is 023910.KQ.
How many shares does Daihan Pharmaceutical Co.,Ltd. have in circulation?
The max supply of Daihan Pharmaceutical Co.,Ltd. shares is 5.88M.
What is Daihan Pharmaceutical Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
Daihan Pharmaceutical Co.,Ltd. PE Ratio is now.
What was Daihan Pharmaceutical Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
Daihan Pharmaceutical Co.,Ltd. EPS is 0 KRW over the trailing 12 months.